ERBB2 and breast cancer: The aberrant activation of PI3K/mTOR/AKT pathway in BC is mediated by the mutation of the PI3KCA gene (more frequent in ER+ and HER-2+) [25], which results in its hyperactivation with consequent dysfunction in the PTEN gene, resulting in AKT overactivation.